tiprankstipranks
Trending News
More News >
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Revenue

Compare
1,902 Followers

VYNE Therapeutics Revenue

VYNE Therapeutics had a revenue of 169.00K in the quarter ending Sep 30, 2025, with 144.93%. This bring the company's revenue in the last twelve months to 524.00K, Decreased 10.08%. In the fiscal year ending Dec 31, 2024, VYNE Therapeutics had annual revenue of 501.00K with 18.16% growth.
Revenue (ttm)
524.00K
Revenue Growth
6.29%
P/S Ratio
38.25
Revenue/Employee
$38,538
Employees
13
Market Cap
$19.16M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
501.00K77.00K+118.16%
Dec 31, 2023
424.00K-53.00K+88.89%
Dec 31, 2022
477.00K-454.00K+51.24%
Dec 31, 2021
931.00K-20.06M+4.43%
Dec 31, 2020
20.99M20.55M+4,738.84%
Dec 31, 2019
443.00K-10.20M+4.16%
Dec 31, 2018
10.64M6.06M+232.21%
Dec 31, 2017
4.58M3.91M+679.82%
Dec 31, 2016
674.00K